EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distribution of Aspergillus species and prevalence of azole resistance in clinical and environmental samples from a Spanish hospital during a three‐year study period

Jose Lucio iD, Laura Alcazar-Fuoli, Horacio Gil, Samuel Cano-Pascual, Sara Hernandez-Egido, Maria Soledad Cuetara, Emilia Mellado iD

Mycoses · 2024-04 · 67 (4)

DOI: 10.1111/myc.13719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, online erschienen am 29.03.2024. Verfasst von Jose Lucio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain. Hauptthemen laut MEDLINE: Aspergillosis, Aspergillus nidulans. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo de Investigación Sanitaria, Center for Biomedical Research in Infectious Diseases (CIBERINFEC-CB21/13/00105), Instituto de Salud Carlos III (ISCIII), Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Surveillance studies are crucial for updating trends in Aspergillus species and antifungal susceptibility information.

Objectives

Determine the Aspergillus species distribution and azole resistance prevalence during this 3‐year prospective surveillance study in a Spanish hospital. Materials and Methods Three hundred thirty‐five Aspergillus spp. clinical and environmental isolates were collected during a 3‐year study. All isolates were screened for azole resistance using an agar‐based screening method and resistance was confirmed by EUCAST antifungal susceptibility testing. The azole resistance mechanism was confirmed by sequencing the cyp 51A gene and its promoter. All Aspergillus fumigatus strains were genotyped using TRESPERG analysis.

Results

Aspergillus fumigatus was the predominant species recovered with a total of 174 strains (51.94%). The rest of Aspergillus spp. were less frequent: Aspergillus niger (14.93%), Aspergillus terreus (9.55%), Aspergillus flavus (8.36%), Aspergillus nidulans (5.37%) and Aspergillus lentulus (3.28%), among other Aspergillus species (6.57%). TRESPERG analysis showed 99 different genotypes, with 72.73% of the strains being represented as a single genotype. Some genotypes were common among clinical and environmental A. fumigatus azole‐susceptible strains, even when isolated months apart. We describe the occurrence of two azole‐resistant A. fumigatus strains, one clinical and another environmental, that were genotypically different and did not share genotypes with any of the azole‐susceptible strains.

Conclusions

Aspergillus fumigatus strains showed a very diverse population although several genotypes were shared among clinical and environmental strains. The isolation of azole‐resistant strains from both settings suggest that an efficient analysis of clinical and environmental sources must be done to detect azole resistance in A. fumigatus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspergillosisAspergillus nidulansHumansAzolesAntifungal AgentsPrevalenceProspective StudiesDrug Resistance, FungalAspergillus fumigatusHospitalsFungal ProteinsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Aspergillus sppTRESPERG genotypingazole resistancehospital environmentsurveillance

Substanzen

AzolesAntifungal AgentsFungal Proteins

Autor:innen und Institutionen

  • Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain.
  • Center for Biomedical Research in Network in Infectious Diseases (CIBERINFEC-CB21/13/00105), Instituto de Salud Carlos III, Madrid, Spain.
  • Microbiology Department, University Hospital Severo Ochoa, Leganés, Madrid, Spain.

ORCID-Profile: Jose Lucio, Emilia Mellado

Förderung

  • Fondo de Investigación Sanitaria
  • Center for Biomedical Research in Infectious Diseases (CIBERINFEC-CB21/13/00105), Instituto de Salud Carlos III (ISCIII)
  • Instituto de Salud Carlos III

Zitieren

APA

Lucio, J., Alcazar-Fuoli, L., Gil, H., Cano-Pascual, S., Hernandez-Egido, S., Cuetara, M. S., & Mellado, E. (2024). Distribution of Aspergillus species and prevalence of azole resistance in clinical and environmental samples from a Spanish hospital during a three‐year study period. Mycoses, 67(4). https://doi.org/10.1111/myc.13719

Vancouver

Lucio J, Alcazar-Fuoli L, Gil H, Cano-Pascual S, Hernandez-Egido S, Cuetara MS, et al. Distribution of Aspergillus species and prevalence of azole resistance in clinical and environmental samples from a Spanish hospital during a three‐year study period. Mycoses. 2024;67(4). doi:10.1111/myc.13719

BibTeX
@article{Lucio2024,
  author = {Lucio, Jose and Alcazar-Fuoli, Laura and Gil, Horacio and Cano-Pascual, Samuel and Hernandez-Egido, Sara and Cuetara, Maria Soledad and Mellado, Emilia},
  title = {Distribution of Aspergillus species and prevalence of azole resistance in clinical and environmental samples from a Spanish hospital during a three‐year study period},
  journal = {Mycoses},
  year = {2024},
  volume = {67},
  number = {4},
  doi = {10.1111/myc.13719}
}
Kostenlos starten →